The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses

On behalf of the Young Academic Urologists Kidney Cancer Working Group of the European Urological Association

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Context: Nephron-sparing approaches are increasingly recommended for incidental small renal masses. Herein, we review the current literature regarding the safety and efficacy of focal therapy, including percutaneous ablation, for small renal masses. Objective: To summarize the application of ablative therapy in the management of small renal masses. Evidence acquisition: PubMed and Medline database search was performed to look for findings published since 2000 on focal therapy for small renal masses. After literature review, 64 articles were selected and discussed. Evidence synthesis: Radiofrequency ablation and cryotherapy are the most widely used procedures with intermediate-term oncological outcome comparable with surgical series. Cost effectiveness seems excellent and side effects appear acceptable. To date, no randomized trial comparing percutaneous focal therapy with standard surgical approach or active surveillance has been performed. Conclusions: Focal ablative therapies are now accepted as effective treatment for small renal tumors. For tumors <3 cm, oncological effectiveness of ablative therapies is comparable with that of partial nephrectomy. Percutaneous ablation has fewer complications and a better postoperative profile when compared with minimally invasive partial nephrectomy. Patient summary: Focal ablative therapies are now accepted as effective treatment for small renal tumors. For tumors <3 cm, oncological effectiveness of ablative therapies is comparable with that of partial nephrectomy. Focal ablative therapies are now accepted as effective treatment for small renal tumors (ie, <3 cm). Percutaneous ablation has fewer complications and a better postoperative profile when compared with partial nephrectomy.

Original languageEnglish (US)
Pages (from-to)395-402
Number of pages8
JournalEuropean Urology Oncology
Volume1
Issue number5
DOIs
StatePublished - Oct 1 2018

Fingerprint

Kidney
Nephrectomy
Therapeutics
Neoplasms
Cryotherapy
Nephrons
PubMed
Cost-Benefit Analysis
Databases
Safety

Keywords

  • Cryoablation
  • Focal therapy
  • Radiofrequency ablation
  • Renal
  • Tumor

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Surgery
  • Oncology
  • Urology

Cite this

On behalf of the Young Academic Urologists Kidney Cancer Working Group of the European Urological Association (2018). The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses. European Urology Oncology, 1(5), 395-402. https://doi.org/10.1016/j.euo.2018.08.029

The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses. / On behalf of the Young Academic Urologists Kidney Cancer Working Group of the European Urological Association.

In: European Urology Oncology, Vol. 1, No. 5, 01.10.2018, p. 395-402.

Research output: Contribution to journalReview article

On behalf of the Young Academic Urologists Kidney Cancer Working Group of the European Urological Association 2018, 'The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses', European Urology Oncology, vol. 1, no. 5, pp. 395-402. https://doi.org/10.1016/j.euo.2018.08.029
On behalf of the Young Academic Urologists Kidney Cancer Working Group of the European Urological Association. The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses. European Urology Oncology. 2018 Oct 1;1(5):395-402. https://doi.org/10.1016/j.euo.2018.08.029
On behalf of the Young Academic Urologists Kidney Cancer Working Group of the European Urological Association. / The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses. In: European Urology Oncology. 2018 ; Vol. 1, No. 5. pp. 395-402.
@article{68b96233c7894c92b8ddd3f9106bdcf6,
title = "The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses",
abstract = "Context: Nephron-sparing approaches are increasingly recommended for incidental small renal masses. Herein, we review the current literature regarding the safety and efficacy of focal therapy, including percutaneous ablation, for small renal masses. Objective: To summarize the application of ablative therapy in the management of small renal masses. Evidence acquisition: PubMed and Medline database search was performed to look for findings published since 2000 on focal therapy for small renal masses. After literature review, 64 articles were selected and discussed. Evidence synthesis: Radiofrequency ablation and cryotherapy are the most widely used procedures with intermediate-term oncological outcome comparable with surgical series. Cost effectiveness seems excellent and side effects appear acceptable. To date, no randomized trial comparing percutaneous focal therapy with standard surgical approach or active surveillance has been performed. Conclusions: Focal ablative therapies are now accepted as effective treatment for small renal tumors. For tumors <3 cm, oncological effectiveness of ablative therapies is comparable with that of partial nephrectomy. Percutaneous ablation has fewer complications and a better postoperative profile when compared with minimally invasive partial nephrectomy. Patient summary: Focal ablative therapies are now accepted as effective treatment for small renal tumors. For tumors <3 cm, oncological effectiveness of ablative therapies is comparable with that of partial nephrectomy. Focal ablative therapies are now accepted as effective treatment for small renal tumors (ie, <3 cm). Percutaneous ablation has fewer complications and a better postoperative profile when compared with partial nephrectomy.",
keywords = "Cryoablation, Focal therapy, Radiofrequency ablation, Renal, Tumor",
author = "{On behalf of the Young Academic Urologists Kidney Cancer Working Group of the European Urological Association} and Maciej Salagierski and Adrianna Wojciechowska and Kinga Zając and Tobias Klatte and Thompson, {R. Houston} and Cadeddu, {Jeffrey A} and Jihad Kaouk and Riccardo Autorino and Kamran Ahrar and Umberto Capitanio",
year = "2018",
month = "10",
day = "1",
doi = "10.1016/j.euo.2018.08.029",
language = "English (US)",
volume = "1",
pages = "395--402",
journal = "European urology oncology",
issn = "2588-9311",
publisher = "Elsevier BV",
number = "5",

}

TY - JOUR

T1 - The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses

AU - On behalf of the Young Academic Urologists Kidney Cancer Working Group of the European Urological Association

AU - Salagierski, Maciej

AU - Wojciechowska, Adrianna

AU - Zając, Kinga

AU - Klatte, Tobias

AU - Thompson, R. Houston

AU - Cadeddu, Jeffrey A

AU - Kaouk, Jihad

AU - Autorino, Riccardo

AU - Ahrar, Kamran

AU - Capitanio, Umberto

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Context: Nephron-sparing approaches are increasingly recommended for incidental small renal masses. Herein, we review the current literature regarding the safety and efficacy of focal therapy, including percutaneous ablation, for small renal masses. Objective: To summarize the application of ablative therapy in the management of small renal masses. Evidence acquisition: PubMed and Medline database search was performed to look for findings published since 2000 on focal therapy for small renal masses. After literature review, 64 articles were selected and discussed. Evidence synthesis: Radiofrequency ablation and cryotherapy are the most widely used procedures with intermediate-term oncological outcome comparable with surgical series. Cost effectiveness seems excellent and side effects appear acceptable. To date, no randomized trial comparing percutaneous focal therapy with standard surgical approach or active surveillance has been performed. Conclusions: Focal ablative therapies are now accepted as effective treatment for small renal tumors. For tumors <3 cm, oncological effectiveness of ablative therapies is comparable with that of partial nephrectomy. Percutaneous ablation has fewer complications and a better postoperative profile when compared with minimally invasive partial nephrectomy. Patient summary: Focal ablative therapies are now accepted as effective treatment for small renal tumors. For tumors <3 cm, oncological effectiveness of ablative therapies is comparable with that of partial nephrectomy. Focal ablative therapies are now accepted as effective treatment for small renal tumors (ie, <3 cm). Percutaneous ablation has fewer complications and a better postoperative profile when compared with partial nephrectomy.

AB - Context: Nephron-sparing approaches are increasingly recommended for incidental small renal masses. Herein, we review the current literature regarding the safety and efficacy of focal therapy, including percutaneous ablation, for small renal masses. Objective: To summarize the application of ablative therapy in the management of small renal masses. Evidence acquisition: PubMed and Medline database search was performed to look for findings published since 2000 on focal therapy for small renal masses. After literature review, 64 articles were selected and discussed. Evidence synthesis: Radiofrequency ablation and cryotherapy are the most widely used procedures with intermediate-term oncological outcome comparable with surgical series. Cost effectiveness seems excellent and side effects appear acceptable. To date, no randomized trial comparing percutaneous focal therapy with standard surgical approach or active surveillance has been performed. Conclusions: Focal ablative therapies are now accepted as effective treatment for small renal tumors. For tumors <3 cm, oncological effectiveness of ablative therapies is comparable with that of partial nephrectomy. Percutaneous ablation has fewer complications and a better postoperative profile when compared with minimally invasive partial nephrectomy. Patient summary: Focal ablative therapies are now accepted as effective treatment for small renal tumors. For tumors <3 cm, oncological effectiveness of ablative therapies is comparable with that of partial nephrectomy. Focal ablative therapies are now accepted as effective treatment for small renal tumors (ie, <3 cm). Percutaneous ablation has fewer complications and a better postoperative profile when compared with partial nephrectomy.

KW - Cryoablation

KW - Focal therapy

KW - Radiofrequency ablation

KW - Renal

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=85067171670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067171670&partnerID=8YFLogxK

U2 - 10.1016/j.euo.2018.08.029

DO - 10.1016/j.euo.2018.08.029

M3 - Review article

C2 - 31158078

AN - SCOPUS:85067171670

VL - 1

SP - 395

EP - 402

JO - European urology oncology

JF - European urology oncology

SN - 2588-9311

IS - 5

ER -